Matthew Lipner
Dermatology · Manchester, NHNPI 1235710831
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.9% of the total across 71 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,304, 4.9 times the $265 reported in 2022.
Across 71 payments — averaging $24.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$264
- Pfizer$235
- Amgen$172
- AbbVie$170
- Arcutis Biotherapeutics, Inc.$167
- Regeneron Healthcare Solutions, Inc.$125
- plus $607 from 14 others
What the payments were for
- Food & beverage$1,61793%
- Education$1247%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 9 | $264 |
| Pfizer | 4 | $235 |
| Amgen | 11 | $172 |
| AbbVie | 15 | $170 |
| Arcutis Biotherapeutics, Inc. | 4 | $167 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Lilly USA, LLC | 2 | $112 |
| Sanofi | 3 | $102 |
| Johnson & Johnson | 3 | $68 |
| E.r. Squibb & Sons, L.L.C. | 3 | $58 |
| Galderma Laboratories, L.p. | 3 | $48 |
| UCB, Inc. | 1 | $41 |
| Biofrontera Inc. | 2 | $41 |
| Botanix SB Inc | 2 | $37 |
| LEO Pharma Inc. | 1 | $26 |
| Incyte Corporation | 1 | $20 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
| Strata Skin Sciences, Inc. | 2 | $15 |
| Redhill Biopharma Inc. | 1 | $14 |
| Organon | 2 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,741 in reported general payments places this provider in the 60th percentile of 75 dermatology providers in New Hampshire.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 29 | $102,373 |
| OtezlaApremilast | 15 | $72,870 |
| Clobetasol Propionate | 32 | $1,738 |
| Dapsone | 14 | $1,300 |
| Halobetasol Propionate | 15 | $1,107 |
| Ketoconazole | 56 | $795 |
| Triamcinolone Acetonide | 44 | $620 |
| Clindamycin Phosphate | 19 | $539 |
| Hydroxychloroquine Sulfate | 14 | $454 |
| MethotrexateMethotrexate Sodium | 25 | $431 |
| Metronidazole | 11 | $415 |
| Prednisone | 22 | $193 |
| Nystatin | 13 | $120 |
| Doxycycline Hyclate | 12 | $75 |
| Fluconazole | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $172 | $72,87015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 75 dermatology providers in New Hampshire.
Other dermatology in Manchester
- Peter JenkinManchester$117K
- Mayra Beauchamp BrunoManchester$162
- Jeanette WatManchester$151
- Jillian RorkManchester$78
- Abel JarellPortsmouth$2.3M
- Robert PosnickNashua$951K
- David PosnickNashua$203K
- Yulianna RussakLebanon$170K
- Neera NathanLondonderry$83K
- Michael LichterNashua$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.